KLOW

KLOW
≥99% Purity, HLPC.
Aliquot injectable vials fully sterilized
Shipped as Lyophilized Powder

BPC-157:
A stable gastric pentadecapeptide that accelerates angiogenesis, fibroblast migration, and epithelial regeneration through modulation of VEGFR2, FAK–paxillin, and nitric oxide signaling pathways. Preclinical data demonstrate enhanced repair of tendon, muscle, and intestinal tissues.
TB-500 (Thymosin Beta-4):
A 43-amino acid actin-sequestering peptide that facilitates tissue regeneration by promoting cell migration, angiogenesis (via VEGF upregulation), and exhibiting anti-inflammatory effects. It mobilizes progenitor cells and expedites repair of myocardial, dermal, and connective tissues.
GHK-Cu:
A copper-binding tripeptide (glycyl-L-histidyl-L-lysine) that promotes wound healing, collagen deposition, and hair follicle activity. It modulates gene expression related to tissue remodeling and exerts antioxidant and anti-inflammatory effects through regulation of TGF-β and matrix metalloproteinases.
KPV (Lysine–Proline–Valine):
A naturally occurring C-terminal tripeptide fragment of α-MSH (alpha–melanocyte-stimulating hormone) recognized for its potent anti-inflammatory and immunomodulatory properties. KPV downregulates proinflammatory cytokines such as TNF-α, IL-1β, and IL-6 via NF-κB inhibition and melanocortin receptor activation. It enhances epithelial barrier integrity and supports mucosal repair in intestinal and dermal inflammation models, showing potential benefits in inflammatory bowel disease, dermatitis, and wound healing.
Synergistic Potential
Combined application of BPC-157, TB-500, GHK-Cu, and KPV may produce synergistic outcomes in tissue regeneration and inflammatory regulation through complementary molecular pathways:
Angiogenesis:
BPC-157 and TB-500 enhance VEGF-mediated vascular growth, while GHK-Cu promotes endothelial proliferation and capillary stabilization—together facilitating nutrient delivery and tissue perfusion during repair.

Cellular Migration and Matrix Remodeling:
TB-500 enhances actin polymerization and cellular motility; BPC-157 and GHK-Cu stimulate fibroblast activation and extracellular matrix synthesis, contributing to organized tissue reconstruction.

Anti-inflammatory and Cytokine Modulation:
KPV complements the antioxidant and anti-inflammatory effects of the other peptides by directly suppressing NF-κB and proinflammatory cytokine release. In combination, all four peptides mitigate oxidative stress and cytokine-driven inflammation, potentially improving outcomes in chronic or complex injuries.

Barrier and Mucosal Restoration:
BPC-157 and KPV act synergistically in maintaining epithelial integrity and accelerating mucosal regeneration, particularly in gastrointestinal and dermal tissues.